Connacht Asset Management LP Seelos Therapeutics, Inc. Transaction History

Connacht Asset Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $118,091 - $215,342	-231,551 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.84 - $1.71 $224,594 - $457,209	-267,374 Reduced 53.59%	231,551 $194,000
Q4 2021 Feb 11, 2022	SELL	$1.59 - $2.38 $65,247 - $97,665	-41,036 Reduced 7.6%	498,925 $813,000
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $214,268 - $366,411	126,786 Added 30.69%	539,961 $1.3 Million
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $1.09 Million - $2.61 Million	413,175 New	413,175 $1.09 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.